Introduction
============

As one of the most common cancers in women around the world,[@b1-ott-11-4339],[@b2-ott-11-4339] cervical cancer led to \>266,000 deaths in 2012 alone.[@b3-ott-11-4339] In China, cervical cancer is the second most common gynecologic cancer among women, with an increasing incidence and mortality.[@b4-ott-11-4339],[@b5-ott-11-4339]

Human papillomavirus (HPV) is a typical risk factor for cervical cancer as the only confirmed cancer-inducing virus so far.[@b6-ott-11-4339] Cervical HPV infection is common,[@b7-ott-11-4339],[@b8-ott-11-4339] with a lifetime risk of 80%--90%.[@b9-ott-11-4339] Although most HPV infections are transitory,[@b10-ott-11-4339] 5%--10% of women with persistent infections remain at an increased risk for the development of cervical intraepithelial neoplasia (CIN) 3 and, less commonly, cervical cancer.[@b11-ott-11-4339]

The immune system of hosts has an important role in controlling HPV infection. Immunosuppressed women have an increased incidence of HPV infection.[@b12-ott-11-4339],[@b13-ott-11-4339] The imbalance of local inflammatory cytokines, including interferon-gamma (IFN-γ), interleukin (IL)-12 and tumor necrosis factor-alpha, is associated with persistent HPV infection.[@b14-ott-11-4339]--[@b16-ott-11-4339] INF-γ has a role in both innate and adaptive immunity,[@b17-ott-11-4339] and can induce cellular resistance to HPV infection.[@b18-ott-11-4339] Both IFN-γ and its receptor (IFN-γR1) genes are key immune response genes.[@b19-ott-11-4339] The IFN-γ gene is located on chromosome 12q24.1 and encodes IFN-γ.[@b20-ott-11-4339] The polymorphism of IFN-γ +874T/A (rs2430561) may affect the production of IFN-γ.[@b21-ott-11-4339] The IFN-γR1 gene locates on chromosome 13q31.3--32.1 and encodes the ligand-binding chain of the IFN-γ receptor.[@b22-ott-11-4339]

In this paper, the association between the polymorphisms of IFN-γ +874T/A (rs2430561), IFN-γR1 −56 T/C (rs2234711), IFN-γR1 +95 C/T (rs7749390) and IFN-γR1 −611A/G (rs 1327474) and HPV susceptibility was investigated in rural women from Luohe, Henan, China. The aim was to identify susceptible genotypes to HPV infection and, thus, provide useful information for vaccination.

Patients and methods
====================

Sampling and randomization strategy
-----------------------------------

This case--control study employed a multistage randomized sampling strategy. One district was selected from five districts in Luohe using computer-generated random selection, and five villages were selected from this selected district. All women meeting the inclusion criteria in these selected villages were detected for HPV infection. The inclusion criteria included: 1) voluntary participation, 2) age ranging from 22 to 70 years and 3) a sexual history of \>3 years. The exclusion criteria included having a medical history of CIN, or cervical cancer, or hysterectomy.

Participants
------------

A total of 260 women were randomly selected and allocated to the case group from the screened women with HPV infection and mild dysplasia or less. The case group was matched by the control group (n=260) according to age and village at a ratio of 1:1. This study was permitted by the ethics committee of Luohe Central Hospital (201402016), and all participants provided written informed consent.

HPV infection testing
---------------------

Cervical tissue cells were collected \>3 days after menstruation and 72 hours after sexual life or vaginal medication from all participants. The sampling brush was rotated softly in the cervical canals to take specimens, and specimens were then stored in a refrigerator at a temperature of 4°C. The HPV infection status in the cervical tissue was tested with Hybrid Capture 2 (HC-2) detector developed by QIAGEN (Hilden, Germany).

Single-nucleotide polymorphism genotyping
-----------------------------------------

DNA for single-nucleotide polymorphism (SNP) genotyping was extracted from the peripheral blood of participants using salting out method according to Hashemi et al.[@b23-ott-11-4339] SNPs of IFN-γ +874T/A, IFN-γR1 −56 T/C, IFN-γR1 +95 C/T and IFN-γR1 −611A/G were genotyped with TaqMan Pre-Designed SNP Genotyping Assays (Applied Biosystems, Carlsbad, CA, USA). Polymerase chain reaction amplification and allelic discrimination were performed according to product specifications using the ABI 7500 Fast real-time polymerase chain reaction system (Applied Biosystems).

Measurement of serum IFN-γ levels
---------------------------------

Serum IFN-γ levels were measured with Human IFN-γ Quantikine ELISA Kit (R&D Systems Europe, Ltd., Abingdon, UK) in all participants, according to the instructions of the manufacturer.

Statistical analysis
--------------------

For all SNPs, Hardy--Weinberg equilibrium test, allele frequencies and genotype frequencies were computed with the SNPstats software (a web tool for the analysis of association studies: net/SNPstats).[@b24-ott-11-4339] All factors, including general data and all SNPs, were compared with a chi-squared test between the case group and the control group. The factors with a *P*-value \<0.10 in univariate analysis were included in the multivariate analysis with a backward stepwise logistic regression model. Multivariate logistic regression analysis was then performed to identify the SNPs associated with HPV susceptibility. Serum IFN-γ levels were compared with analysis of variance between different genotypes. The SPSS version 22.0 for Windows (IBM Corporation, Armonk, NY, USA) was employed to perform all statistical analyses. Significance was set at *P*\<0.05.

Results
=======

General data
------------

The average age of all participants was 41.58±9.46 years. According to the results of univariate analysis, annual family income, education level and occupation were statistically different between the case group and the control group, and race, and marital, drinking and smoking status were not statistically different ([Table 1](#t1-ott-11-4339){ref-type="table"}).

SNP analysis
------------

The success rates of genotyping of all SNPs were 100% in both the control group and the case group. The genotype frequencies of all SNPs did not deviate significantly from those expected under Hardy--Weinberg equilibrium ([Table 2](#t2-ott-11-4339){ref-type="table"}). According to the results of univariate analysis, the genotype frequencies of IFN-γ +874T/A and IFN-γR1 −56 T/C were statistically different between the case group and the control group (*P*\<0.05), and those of IFN-γR1 +95 C/T and IFN-γR1 −611A/G were not statistically different (*P*\>0.05).

Multivariate analysis
---------------------

Multivariate logistic regression analysis was performed to determine the association between different genotypes of IFN-γ +874T/A and IFN-γR1 −56 T/C and HPV susceptibility, adjusting for age, annual family income, education level, occupation and smoking status ([Table 3](#t3-ott-11-4339){ref-type="table"}). According to the results of multivariate analysis, the polymorphism of IFN-γ +874T/A was associated with HPV susceptibility, and +874A carriers had an increased risk of HPV infection. Moreover, the odds ratio (OR) was higher in +874 AA carriers than in +874 AT carriers ([Figure 1](#f1-ott-11-4339){ref-type="fig"}).

Serum IFN-γ levels
------------------

The results of analysis of variance showed that serum IFN-γ levels were highest in IFN-γ +874 TT carriers, intermediate in AT carriers and lowest in AA carriers ([Table 4](#t4-ott-11-4339){ref-type="table"}).

Discussion
==========

Cytokines have a pivotal role in establishing and maintaining immune responses against virus infection.[@b25-ott-11-4339] Polymorphisms of regulating regions of cytokine genes, including *IFN-γ*, *IL-6*, *IL-10*, *transforming growth factor beta 1* (*TGF*-β*1*) and *TNF* genes, have been associated with their production, which lead to difference in susceptibility to virus infection.[@b26-ott-11-4339]--[@b30-ott-11-4339] HPV infection is very common among women. However, the virus is eliminated in most infected women (70%--90%) 12--24 months after the initial diagnosis without any intervention.[@b31-ott-11-4339],[@b32-ott-11-4339]

The exact mechanism associated with the clearance of HPV infection remains uncertain. Both the innate and adaptive immune responses are involved in the clearance, persistence or progression of HPV infection.[@b33-ott-11-4339] The innate immune response is thought to be critical in early control of HPV infection as the first line of defense against invading pathogens.[@b34-ott-11-4339] It can coordinate the host responses to prevent or reduce viral replication and spread, until the adaptive immune system is established.[@b35-ott-11-4339] Most cervical HPV infections are eliminated or suppressed through cell-mediated immunity with CD4+ and CD8+ T cells as the major effector cells,[@b36-ott-11-4339] and the Th1 response is associated with clearance of the HPV infection.[@b37-ott-11-4339]

As a T-helper 1 proinflammatory cytokine, IFN-γ is produced during virus infection. IFN-γ has a pivotal role in defense against HPV through inducing cell-mediated inflammatory responses.[@b38-ott-11-4339],[@b39-ott-11-4339] Telesheva et al found that the outcome of HPV infection is correlated with the interferon component of the immune response.[@b40-ott-11-4339] A persistent HPV infection is characterized by decreased levels of IFN-α, and transient infection is associated with increased levels of IFN-γ and IFN-α. Song et al investigated 57 women with high-risk HPV (HR-HPV) infection and untreated mild dysplasia or less. After a follow-up period of 12 months, HPV was not detectable in 93.3% (28/30) of women who were IFN-γ positive and in 66.7% (18/27) of women who were IFN-γ negative. Multivariate analysis showed that IFN-γ-positive status was significantly associated with clearance of HR-HPV (OR: 8.26; 95% CI: 1.24--54.94). Therefore, they concluded that IFN-γ may be a prognostic marker for clearance of HR-HPV.[@b15-ott-11-4339]

As the encoding gene of IFN-γ, *IFN-γ* gene may affect the production of IFN-γ through an SNP located in the first intron at the 5′ end adjacent to a CA repeat region (+874T/A polymorphism).[@b21-ott-11-4339] IFN-γ +874 TT genotype produces a high level of IFN-γ and helps the host's defense against viral infection. Conversely, the genotypes AA and AT cause low IFN-γ production, which may increase the risk of viral infection.[@b41-ott-11-4339]--[@b45-ott-11-4339]

According to our results, the polymorphism of IFN-γ +874T/A was associated with HPV susceptibility, and +874A carriers had an increased risk of HPV infection. Moreover, the OR was higher in +874 AA carriers than in +874 AT carriers. The serum levels of IFN-γ were +874 TT carriers\>AT carriers\>AA carriers. Therefore, the polymorphism of IFN-γ +874T/A affected HPV susceptibility through modulating the production of IFN-γ. Meanwhile, the polymorphisms of IFN-γR1 −56 T/C, IFN-γR1 +95 C/T and IFN-γR1 −611A/G were not associated with HPV susceptibility, and the serum levels of IFN-γ were not statistically different between different genotypes.

Conclusion
==========

The polymorphism of IFN-γ +874T/A was associated with HPV susceptibility in rural women from Luohe, Henan, China, and +874A carriers had an increased risk of HPV infection. The possible mechanism was that +874A carriers had a low production of IFN-γ.
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###### 

General data of the case group and the control group

  Variables                       Case group (n=260)   Control group (n=260)   *χ*^2^   *P*-value
  ------------------------------- -------------------- ----------------------- -------- -----------
  Race                                                                                  
   Han                            251 (96.54%)         250 (96.15%)            0.055    \>0.05
   Hui/Mongol/Manchu              9 (3.46%)            10 (3.85%)                       
  Educational level                                                                     
   Primary school and below       79 (30.38%)          56 (21.54%)             28.626   \<0.001
   Junior high school             144 (55.38%)         115 (44.23%)                     
   Senior high school and above   37 (14.24%)          89 (34.23%)                      
  Occupation                                                                            
   Farmer                         218 (83.85%)         177 (68.08%)            18.001   \<0.001
   Worker                         29 (11.15%)          53 (20.38%)                      
   Civil servant/teacher/doctor   13 (5.00%)           30 (11.54%)                      
  Annual family income (RMB)                                                            
   \<10,000                       199 (76.54%)         148 (56.92%)            26.01    \<0.001
   10,000--20,000                 42 (16.15%)          60 (23.08%)                      
   \>20,000                       19 (7.31%)           52 (20.00%)                      
  Marital status                                                                        
   Married                        245 (94.23%)         249 (95.77%)            0.648    \>0.05
   Unmarried/divorced             15 (5.77%)           11 (4.23%)                       
  Drinking status                                                                       
   Yes                            234 (90.00%)         239 (91.92%)            0.585    \>0.05
   No                             26 (10.00%)          21 (8.08%)                       
  Smoking status                                                                        
   Yes                            228 (87.69%)         238 (91.54%)            2.066    \>0.05
   No                             32 (12.31%)          22 (8.46%)                       

**Note:** Case group, women with HPV infection and mild dysplasia or less; control group, women without HPV infection.

**Abbreviations:** HPV, human papillomavirus; RMB, Renminbi.

###### 

Allele and genotype frequencies of the case group and the control group

  Single-nucleotide polymorphisms                           Allele frequency   Genotype frequency         HWE *P*-value         
  --------------------------------------------------------- ------------------ -------------------- ----- --------------- ----- --------
  IFN-γ +874T/A                                             T                  A                    TT    AT              AA    
   Case group[\*](#tfn3-ott-11-4339){ref-type="table-fn"}   224                296                  72    80              108   \>0.05
   Control group                                            302                218                  119   79              62    \>0.05
  IFN-γR1 −56 T/C                                           T                  C                    TT    CT              CC    
   Case group[\*](#tfn3-ott-11-4339){ref-type="table-fn"}   251                269                  64    123             73    \>0.05
   Control group                                            225                295                  41    143             76    \>0.05
  IFN-γR1 +95 C/T                                           C                  T                    CC    CT              TT    
   Case group                                               252                268                  67    118             75    \>0.05
   Control group                                            249                271                  62    125             73    \>0.05
  IFN-γR1 −611A/G                                           A                  G                    AA    AG              GG    
   Case group                                               467                53                   218   31              11    \>0.05
   Control group                                            458                62                   213   32              15    \>0.05

**Notes:**

*P*\<0.05, vs genotype frequency of the control group.

**Abbreviations:** HWE, Hardy--Weinberg equilibrium; IFN, interferon.

###### 

Association between polymorphism of IFN-γ +874T/A, IFN-γR1 −56 T/C, IFN-γR1 +95 C/T, IFN-γR1 −611A/G and HPV susceptibility

  Genotypes      Regression coefficient   Standard error   Wald     OR      95% CI          *P*-value
  -------------- ------------------------ ---------------- -------- ------- --------------- -----------
  IFN-γ +874                                               10.668                           0.003
   TT                                                               --      --              Ref=1
   AT            0.316                    0.167            8.639    1.672   1.0912--2.563   0.014
   AA            0.425                    0.226            12.639   2.874   1.872--4.414    \<0.001
  IFN-γR1 −56                                              1.217                            0.203
   TT                                                               --      --              Ref=1
   CT            0.249                    0.136            1.329    0.551   0.232--1.157    0.187
   CC            0.273                    0.148            1.208    0.615   0.396--1.398    0.209
  IFN-γR1 +95                                              1.054                            0.264
   CC                                                               --      --              Ref=1
   CT            0.357                    0.192            1.145    0.874   0.491--1.586    0.241
   TT            0.282                    0.159            0.967    0.951   0.619--1.835    0.318
  IFN-γR1 −611                                             0.987                            0.296
   AA                                                               --      --              Ref=1
   AG            0.174                    0.126            0.871    0.946   0.608--1.826    0.349
   GG            0.225                    0.137            1.238    0.717   0.401--1.479    0.195

**Abbreviations:** HPV, human papillomavirus; IFN, interferon; OR, odds ratio; Ref, reference.

###### 

Serum IFN-γ levels in different genotypes of IFN-γ +874T/A

  Genotypes       Different genotypes (n)   Serum IFN-γ levels (pg/mL)
  --------------- ------------------------- ---------------------------------------------------------------------------------------------------
  IFN-γ +874 TT   72                        2.86±1.14
  IFN-γ +874 AT   80                        1.57±0.79[\*](#tfn3-ott-11-4339){ref-type="table-fn"}
  IFN-γ +874 AA   108                       0.41±0.22[\*](#tfn6-ott-11-4339){ref-type="table-fn"},[‡](#tfn7-ott-11-4339){ref-type="table-fn"}
  *F*                                       8.947
  *P*-value                                 \<0.001

**Notes:**

*P*\<0.05, vs IFN-γ +874 TT.

*P*\<0.05, vs IFN-γ +874 AT.

**Abbreviation:** IFN, interferon.
